idarucizumab

FDA Drug Profile — Praxbind

idarucizumab is listed in the FDA National Drug Code directory with 3 NDC codes, marketed under brand name including Praxbind. Available dosage forms: liquid, injection.

Drug details

Generic Name
idarucizumab
Brand Names
Praxbind
Application Number
BLA761025
Sponsor
Boehringer Ingelheim Pharma GmbH And Co. KG
NDC Codes
3
Dosage Forms
LIQUID, INJECTION
Routes
INTRAVENOUS
Active Ingredients
IDARUCIZUMAB

Indications and Usage

1 INDICATIONS AND USAGE PRAXBIND is indicated in patients treated with Pradaxa when reversal of the anticoagulant effects of dabigatran is needed: For emergency surgery/urgent procedures In life-threatening or uncontrolled bleeding PRAXBIND is a humanized monoclonal antibody fragment (Fab) indicated in patients treated with Pradaxa ® when reversal of the anticoagulant effects of dabigatran is needed: For emergency surgery/urgent procedures In life-threatening or uncontrolled bleeding ( 1 )

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.